Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT03398837 · TERMINATED
Trial details
- NCT number
- NCT03398837
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2020-05-27
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.